Wednesday, June 18, 2025
spot_img

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.

The affected lots were distributed nationwide in the United States through retailers and online from 12/14/2022 through 06/04/2025.

The table below identifies the UPC, lot numbers, and expiration dates of the Little Remedies® Honey Cough Syrup impacted by this recall.

Item UPC Lot # Exp. Date
7-56184-10737-9 0039 11/2025
0545 01/2026
0640 02/2026
0450 05/2026
1198 12/2026

Little Remedies® Honey Cough Syrup is packaged in a 4 FL OZ (118 mL) amber bottle and is sold in an outer carton with the Lot Code appearing both on the bottle label and on the bottom of the carton (images below).

This recall does not include any other Little Remedies® products.

Bottle Label:

Bottle Label:

Carton:

Carton:

No serious adverse events have been reported to date.

All lots of Little Remedies® Honey Cough 4 FL OZ (118 mL) still within expiry are being included in the scope of the recall.

Consumers who have the recalled Product should stop using it immediately and should contact their physician or healthcare provider if they have experienced any problems that may be related to the use of this Product. The company will also offer reimbursement for consumers who have purchased Products from the recalled lots.

Consumers with refund requests or questions regarding this recall can contact Medtech via e-mail at [email protected], through its website at https://www.prestigebrands.com/contact, or by phone at (800) 754-8853 on Monday – Friday 8:30-5:30 eastern time.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online: www.fda.gov/medwatch/report.htm
  • Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/ca32fb6c-5efc-4785-bf61-239d42d91bfb

https://www.globenewswire.com/NewsRoom/AttachmentNg/fca77e04-87d0-45ef-b10e-7b13ae6e4adc

Powered by SlickText.com

Hot this week

Biomea Fusion Announces Pricing of Public Offering of Securities

REDWOOD CITY, Calif., June 17, 2025 (GLOBE...

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

~Record Participation for SBC Medical. 22 doctors Present Insights...

High Arctic Overseas Announces Normal Course Issuer Bid

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR...

EHang and Gotion High-Tech Join Forces to Power the Future of Low-Altitude Economy

GUANGZHOU, China, June 18, 2025 (GLOBE NEWSWIRE)...

Pioneer Acquisition I Corp Announces Pricing of $220,000,000 Initial Public Offering

BROOKLYN, N.Y., June 17, 2025 (GLOBE NEWSWIRE)...

Topics

spot_img

Related Articles

Popular Categories

spot_img